-
1
-
-
0012698942
-
p21 Ras is modified by a farnesyl isoprenoid
-
Casey, P.J., Solski, P.A., Der, C.J., Buss, J.E. p21 Ras is modified by a farnesyl isoprenoid. Proc Natl Acad Sci USA 1989, 86: 8323-7.
-
(1989)
Proc Natl Acad Sci USA
, vol.86
, pp. 8323-8327
-
-
Casey, P.J.1
Solski, P.A.2
Der, C.J.3
Buss, J.E.4
-
2
-
-
0024406286
-
All ras proteins are polyisoprenylated but only some are palmitoylated
-
Hancock, J.F., Magee, A.I., Chilad, J.E., Marshall, C.J. All ras proteins are polyisoprenylated but only some are palmitoylated. Cell 1989, 57: 1167-77.
-
(1989)
Cell
, vol.57
, pp. 1167-1177
-
-
Hancock, J.F.1
Magee, A.I.2
Chilad, J.E.3
Marshall, C.J.4
-
3
-
-
0024316475
-
Genetic and pharmacological suppression of oncogenic mutations in ras genes of yeast and humans
-
Schafer, W.R., Kim, R., Sterne, R., Thorner, J., Kim, S-H., Rine, J. Genetic and pharmacological suppression of oncogenic mutations in ras genes of yeast and humans. Science 1989, 245: 379-85.
-
(1989)
Science
, vol.245
, pp. 379-385
-
-
Schafer, W.R.1
Kim, R.2
Sterne, R.3
Thorner, J.4
Kim, S.-H.5
Rine, J.6
-
4
-
-
0000504764
-
Purification of ras farnesyl protein transferase
-
Reiss, Y., Seabra, M.C., Goldstein, J.L., Brown, M.S. Purification of ras farnesyl protein transferase. Methods: A Companion to Methods in Enzymology 1990, 1: 241-5.
-
(1990)
Methods: A Companion to Methods in Enzymology
, vol.1
, pp. 241-245
-
-
Reiss, Y.1
Seabra, M.C.2
Goldstein, J.L.3
Brown, M.S.4
-
5
-
-
0025194466
-
Inhibition of purified p21 ras farnesyl:Protein transferase by Cys-AAX tetrapeptides
-
Reiss, Y., Goldstein, J.L., Seabra, M.C., Casey, P.J., Brown, M.S. Inhibition of purified p21 ras farnesyl:protein transferase by Cys-AAX tetrapeptides. Cell 1990, 62: 81-8.
-
(1990)
Cell
, vol.62
, pp. 81-88
-
-
Reiss, Y.1
Goldstein, J.L.2
Seabra, M.C.3
Casey, P.J.4
Brown, M.S.5
-
6
-
-
0026521412
-
Endoproteolytic processing of a farnesylated peptide in vitro
-
Ashby, M.N., King, D.S., Rine, J. Endoproteolytic processing of a farnesylated peptide in vitro. Proc Natl Acad Sci USA 1992, 89: 4613-7.
-
(1992)
Proc Natl Acad Sci USA
, vol.89
, pp. 4613-4617
-
-
Ashby, M.N.1
King, D.S.2
Rine, J.3
-
7
-
-
0026680433
-
A microsomal endoprotease that specifically cleaves isoprenylated peptides
-
Ma, Y-T., Rando, R.R. A microsomal endoprotease that specifically cleaves isoprenylated peptides. Proc Natl Acad Sci USA 1992, 89: 6275-9.
-
(1992)
Proc Natl Acad Sci USA
, vol.89
, pp. 6275-6279
-
-
Ma, Y.-T.1
Rando, R.R.2
-
8
-
-
0031664339
-
Roles of prenyl protein proteases in maturation of Saccharomyces cerevisiae α-factor
-
Boyartchuk, V.L., Rine, J. Roles of prenyl protein proteases in maturation of Saccharomyces cerevisiae α-factor. Genetics 1998, 150: 95-101.
-
(1998)
Genetics
, vol.150
, pp. 95-101
-
-
Boyartchuk, V.L.1
Rine, J.2
-
9
-
-
0033605743
-
Cloning and characterization of a mammalian prenyl protein specific protease
-
Otto, J.C., Kim, E., Young, S.G., Casey, P.J. Cloning and characterization of a mammalian prenyl protein specific protease. J Biol Chem 1999, 274: 8379-82.
-
(1999)
J Biol Chem
, vol.274
, pp. 8379-8382
-
-
Otto, J.C.1
Kim, E.2
Young, S.G.3
Casey, P.J.4
-
10
-
-
0000081175
-
Posttranslational modification of the Ha-ras oncogene protein: Evidence for a third class of protein carboxyl methyltransferases
-
Clarke, S., Vogel, J.P., Deschenes, R.J., Stock, J. Posttranslational modification of the Ha-ras oncogene protein: Evidence for a third class of protein carboxyl methyltransferases. Proc Natl Acad Sci USA 1988, 85: 4643-6.
-
(1988)
Proc Natl Acad Sci USA
, vol.85
, pp. 4643-4646
-
-
Clarke, S.1
Vogel, J.P.2
Deschenes, R.J.3
Stock, J.4
-
11
-
-
0026346215
-
Methylation and demethylation reactions of guanine nucleotidebinding proteins of retinal rod outer segments
-
Perez-Sala, D., Tan, E.W., Canada, F.J., Rando, R.R. Methylation and demethylation reactions of guanine nucleotidebinding proteins of retinal rod outer segments. Proc Natl Acad Sci USA 1991, 88, 3043-6.
-
(1991)
Proc Natl Acad Sci USA
, vol.88
, pp. 3043-3046
-
-
Perez-Sala, D.1
Tan, E.W.2
Canada, F.J.3
Rando, R.R.4
-
12
-
-
0029789954
-
Purification of a protein palmitoyl transferase that acts on H-Ras protein and on C-terrninal N-ras peptide
-
Liu, L., Dudler, T., Gelb, M.H. Purification of a protein palmitoyl transferase that acts on H-Ras protein and on C-terrninal N-ras peptide. J Biol Chem 1996, 271: 23269-76.
-
(1996)
J Biol Chem
, vol.271
, pp. 23269-23276
-
-
Liu, L.1
Dudler, T.2
Gelb, M.H.3
-
13
-
-
0029127725
-
Binding of prenylated and polybasic peptides to membranes: Affinities and intervesicle exchange
-
Ghomashchi, F., Zhang, X., Liu, L., Gelb, M. Binding of prenylated and polybasic peptides to membranes: Affinities and intervesicle exchange. Biochemistry 1995, 34: 11910-8.
-
(1995)
Biochemistry
, vol.34
, pp. 11910-11918
-
-
Ghomashchi, F.1
Zhang, X.2
Liu, L.3
Gelb, M.4
-
14
-
-
0030909826
-
Crystal structure of protein farnesyl transferase at 2.25 Å resolution
-
Park, H., Boduliri, S., Moomaw, J., Casey, P., Beese, L. Crystal structure of protein farnesyl transferase at 2.25 Å resolution. Science 1997, 275: 1800-4.
-
(1997)
Science
, vol.275
, pp. 1800-1804
-
-
Park, H.1
Boduliri, S.2
Moomaw, J.3
Casey, P.4
Beese, L.5
-
15
-
-
0032564385
-
Crystal structure of farnesyl protein transferase complexed with a CaaX peptide and farnesyl diphosphate analogue
-
Strickland, C.L., Windsor, W.T., Syto, R. et al. Crystal structure of farnesyl protein transferase complexed with a CaaX peptide and farnesyl diphosphate analogue. Biochemistry 1998, 37: 16601-11.
-
(1998)
Biochemistry
, vol.37
, pp. 16601-16611
-
-
Strickland, C.L.1
Windsor, W.T.2
Syto, R.3
-
16
-
-
0023068346
-
The ras oncogen
-
Barbacid, M. The ras oncogen. Annu Rev Biochem 1987, 56: 779-828.
-
(1987)
Annu Rev Biochem
, vol.56
, pp. 779-828
-
-
Barbacid, M.1
-
17
-
-
0028835253
-
A peptidomimetic inhibitor of farnesyl:Protein transferase blocks the anchorage-dependent and independent growth of human tumor cell lines
-
Sepp-Lorenzino, L., Ma, Z., Rands, E. et al. A peptidomimetic inhibitor of farnesyl:protein transferase blocks the anchorage-dependent and independent growth of human tumor cell lines. Cancer Res 1995, 55: 5302-9.
-
(1995)
Cancer Res
, vol.55
, pp. 5302-5309
-
-
Sepp-Lorenzino, L.1
Ma, Z.2
Rands, E.3
-
18
-
-
0033016719
-
Cell growth inhibition by farnesyltransferase inhibitors is mediated by gain of geranylgeranylated RhoB
-
Du, W., Lebowitz, P.F., Prendergast, G.C. Cell growth inhibition by farnesyltransferase inhibitors is mediated by gain of geranylgeranylated RhoB. Mol Cell Biol 1999, 19: 1831-40.
-
(1999)
Mol Cell Biol
, vol.19
, pp. 1831-1840
-
-
Du, W.1
Lebowitz, P.F.2
Prendergast, G.C.3
-
19
-
-
0030865773
-
Ras farnesyltransferase: A new therapeutic target
-
Leonard, D.M. Ras farnesyltransferase: A new therapeutic target. J Med Chem 1997, 30: 2971-90.
-
(1997)
J Med Chem
, vol.30
, pp. 2971-2990
-
-
Leonard, D.M.1
-
20
-
-
0031943826
-
Inhibitors of protein farnesylation 1998
-
Williams, T.M. Inhibitors of protein farnesylation 1998. Exp Opin Ther Patents 1998, 8: 553-69.
-
(1998)
Exp Opin Ther Patents
, vol.8
, pp. 553-569
-
-
Williams, T.M.1
-
21
-
-
0026040193
-
Nonfarnesylated tetrapeptide inhibitors of protein farnesyltransferase
-
Goldstein, J.L., Brown, M.S., Stradley, S.J., Reiss, Y., Gierasch, L.M. Nonfarnesylated tetrapeptide inhibitors of protein farnesyltransferase. J Biol Chem 1991, 266: 15575-8.
-
(1991)
J Biol Chem
, vol.266
, pp. 15575-15578
-
-
Goldstein, J.L.1
Brown, M.S.2
Stradley, S.J.3
Reiss, Y.4
Gierasch, L.M.5
-
22
-
-
0027248872
-
Selective inhibition of ras-dependent transformation by a farnesyltransferase inhibitor
-
Kohl, N. E., Mosser, S.D., de Solms, S.J. et al. Selective inhibition of ras-dependent transformation by a farnesyltransferase inhibitor. Science 1993, 260: 1934-7.
-
(1993)
Science
, vol.260
, pp. 1934-1937
-
-
Kohl, N.E.1
Mosser, S.D.2
De Solms, S.J.3
-
23
-
-
0028211246
-
Pseudopeptide inhibitors of ras farnesyl-protein transferase
-
Graham, S.L., de Solms, S.J., Giuliani, E.A. et al. Pseudopeptide inhibitors of ras farnesyl-protein transferase. J Med Chem 1994, 37: 725-32.
-
(1994)
J Med Chem
, vol.37
, pp. 725-732
-
-
Graham, S.L.1
De Solms, S.J.2
Giuliani, E.A.3
-
24
-
-
0028603395
-
Protein farnesyltransferase inhibitors block the growth of ras-dependent tumors in nude mice
-
Kohl, N.E., Wilson, F.R., Mosser, S.D. et al. Protein farnesyltransferase inhibitors block the growth of ras-dependent tumors in nude mice. Proc Natl Acad Sci USA 1994, 91: 9141-5.
-
(1994)
Proc Natl Acad Sci USA
, vol.91
, pp. 9141-9145
-
-
Kohl, N.E.1
Wilson, F.R.2
Mosser, S.D.3
-
25
-
-
0028318136
-
Farnesyltransferase inhibition causes morphological reversion of ras-transformed cells by a complex mechanism that involves regulation of the actin cytoskeleton
-
Prendergast, G.C., Davide, J.P., de Solms, S.J. et al. Farnesyltransferase inhibition causes morphological reversion of ras-transformed cells by a complex mechanism that involves regulation of the actin cytoskeleton. Mol Cell Biol 1994, 14: 4193-202.
-
(1994)
Mol Cell Biol
, vol.14
, pp. 4193-4202
-
-
Prendergast, G.C.1
Davide, J.P.2
De Solms, S.J.3
-
26
-
-
0029150669
-
Inhibition of farnesyltransferase induces regression of mammary and salivary carcinomas in ras transgenic mice
-
Kohl, N.E., Omer, C.A., Conner, M.W. et al. Inhibition of farnesyltransferase induces regression of mammary and salivary carcinomas in ras transgenic mice. Nat Med 1995, 1: 792-7.
-
(1995)
Nat Med
, vol.1
, pp. 792-797
-
-
Kohl, N.E.1
Omer, C.A.2
Conner, M.W.3
-
27
-
-
0031983131
-
A farnesyltransferase inhibitor induces tumor regression in transgenic mice harboring multiple oncogenic mutations by mediating alterations in both cell cycle control and apoptosis
-
Barrington, R.E., Subler, M.A., Rands, E. et al. A farnesyltransferase inhibitor induces tumor regression in transgenic mice harboring multiple oncogenic mutations by mediating alterations in both cell cycle control and apoptosis. Mol Cell Biol 1998, 18: 85-92.
-
(1998)
Mol Cell Biol
, vol.18
, pp. 85-92
-
-
Barrington, R.E.1
Subler, M.A.2
Rands, E.3
-
28
-
-
0027320616
-
Peptidomimetic inhibitors of ras farnesylation and function in whole cells
-
Garcia, A.M., Rowell, C., Ackermann, K., Kowalczyk, J.J., Lewis, M.D. Peptidomimetic inhibitors of ras farnesylation and function in whole cells. J Biol Chem 1993, 268: 18415-8.
-
(1993)
J Biol Chem
, vol.268
, pp. 18415-18418
-
-
Garcia, A.M.1
Rowell, C.2
Ackermann, K.3
Kowalczyk, J.J.4
Lewis, M.D.5
-
29
-
-
0027998986
-
The CAAX peptidomimetic compound B581 specifically blocks farnesylated, but not geranylgeranylated or myristylated, oncogenic ras signaling and transformation
-
Cox, A.D., Garcia, A.M., Westwick, J.K. et al. The CAAX peptidomimetic compound B581 specifically blocks farnesylated, but not geranylgeranylated or myristylated, oncogenic ras signaling and transformation. J Biol Chem 1994, 269: 19203-6.
-
(1994)
J Biol Chem
, vol.269
, pp. 19203-19206
-
-
Cox, A.D.1
Garcia, A.M.2
Westwick, J.K.3
-
30
-
-
0028869067
-
Inhibition of human tumor xenograft growth by treatment with the farnesyl transferase inhibitor B956
-
Nagasu, T., Yoshimatsu, K., Rowell, C., Lewis, M.D., Garcia, A.M. Inhibition of human tumor xenograft growth by treatment with the farnesyl transferase inhibitor B956. Cancer Res 1995, 55: 5310-4.
-
(1995)
Cancer Res
, vol.55
, pp. 5310-5314
-
-
Nagasu, T.1
Yoshimatsu, K.2
Rowell, C.3
Lewis, M.D.4
Garcia, A.M.5
-
31
-
-
0027323459
-
Benzodiazepine peptidomimetics: Potent inhibitors of ras farnesylation in animal cells
-
James, G.L., Goldstein, J.L., Brown, M.S. et al. Benzodiazepine peptidomimetics: Potent inhibitors of ras farnesylation in animal cells. Science 1993, 260: 1937-42.
-
(1993)
Science
, vol.260
, pp. 1937-1942
-
-
James, G.L.1
Goldstein, J.L.2
Brown, M.S.3
-
32
-
-
0028063058
-
Benzodiazepine peptidomimetic BZA-5B interrupts the MAP kinase activation pathway in H-ras-transformed rat-1 cells, but not in untransformed cells
-
James, G.L., Brown, M.S., Cobb, M.H., Goldstein, J.L. Benzodiazepine peptidomimetic BZA-5B interrupts the MAP kinase activation pathway in H-ras-transformed rat-1 cells, but not in untransformed cells. J Biol Chem 1994, 269: 27705-14.
-
(1994)
J Biol Chem
, vol.269
, pp. 27705-27714
-
-
James, G.L.1
Brown, M.S.2
Cobb, M.H.3
Goldstein, J.L.4
-
33
-
-
0029091930
-
The farnesyl protein transferase inhibitor BZA-5B blocks farnesylation of nuclear lamins and p21 ras but does not affect their function or localization
-
Dalton, M.B., Fantle, K.S., Bechtold, H.A. et al. The farnesyl protein transferase inhibitor BZA-5B blocks farnesylation of nuclear lamins and p21 ras but does not affect their function or localization. Cancer Res 1995, 55: 3295-304.
-
(1995)
Cancer Res
, vol.55
, pp. 3295-3304
-
-
Dalton, M.B.1
Fantle, K.S.2
Bechtold, H.A.3
-
35
-
-
0028352281
-
Design and structural requirements of potent peptidomimetic inhibitors of p21 ras farnesyltransferase
-
Qian, Y., Blaskovich, M.A., Saleem, M. et al. Design and structural requirements of potent peptidomimetic inhibitors of p21 ras farnesyltransferase. J Biol Chem 1994, 269: 12410-3.
-
(1994)
J Biol Chem
, vol.269
, pp. 12410-12413
-
-
Qian, Y.1
Blaskovich, M.A.2
Saleem, M.3
-
36
-
-
0028132044
-
Peptidomimetic inhibitors of p21 ras farnesyl transferase: Hydrophobic functionalization leads to disruption of p21 ras membrane association in whole cells
-
Qian, Y., Blaskovich, M.A., Seong, C-M., Vogt, A., Hamilton, A.D., Sebti, S.M. Peptidomimetic inhibitors of p21 ras farnesyl transferase: Hydrophobic functionalization leads to disruption of p21 ras membrane association in whole cells. Bioorg Med Chem Lett 1994, 4: 2579-84.
-
(1994)
Bioorg Med Chem Lett
, vol.4
, pp. 2579-2584
-
-
Qian, Y.1
Blaskovich, M.A.2
Seong, C.-M.3
Vogt, A.4
Hamilton, A.D.5
Sebti, S.M.6
-
37
-
-
0028973293
-
Ras CAAX peptidomimetic FTI-277 selectively blocks oncogenic ras signaling by inducing cytoplasmic accumulation of inactive ras-raf complexes
-
Lerner, E.C., Qian, Y., Blaskovich, M.A. et al. Ras CAAX peptidomimetic FTI-277 selectively blocks oncogenic ras signaling by inducing cytoplasmic accumulation of inactive ras-raf complexes. J Biol Chem 1995, 270: 26802-6.
-
(1995)
J Biol Chem
, vol.270
, pp. 26802-26806
-
-
Lerner, E.C.1
Qian, Y.2
Blaskovich, M.A.3
-
38
-
-
0029023145
-
Ras CAAX peptidomimetic FTI-276 selectively blocks tumor growth in nude mice of a human lung carcinoma with K-ras mutation and p53 deletion
-
Sun, J., Qian, Y., Hamilton, A.D., Sebti, S.M. Ras CAAX peptidomimetic FTI-276 selectively blocks tumor growth in nude mice of a human lung carcinoma with K-ras mutation and p53 deletion. Cancer Res 1995, 55: 4243-7.
-
(1995)
Cancer Res
, vol.55
, pp. 4243-4247
-
-
Sun, J.1
Qian, Y.2
Hamilton, A.D.3
Sebti, S.M.4
-
39
-
-
0028912593
-
A non-peptide mimetic of ras-CAAX: Selective inhibition of farnesyltransferase and ras processing
-
Vogt, A., Qian, Y., Blaskovich, M.A., Fossum, R.D., Hamilton, A.D., Sebti, S.M. A non-peptide mimetic of ras-CAAX: Selective inhibition of farnesyltransferase and ras processing. J Biol Chem 1995, 270: 660-4.
-
(1995)
J Biol Chem
, vol.270
, pp. 660-664
-
-
Vogt, A.1
Qian, Y.2
Blaskovich, M.A.3
Fossum, R.D.4
Hamilton, A.D.5
Sebti, S.M.6
-
40
-
-
15144355763
-
Potent and selective non-cysteine-containing inhibitors of protein farnesyltransferase
-
Augeri, D.J., O'Connor, S.J., Janowick, D. et al. Potent and selective non-cysteine-containing inhibitors of protein farnesyltransferase. J Med Chem 1998, 41: 4288-300.
-
(1998)
J Med Chem
, vol.41
, pp. 4288-4300
-
-
Augeri, D.J.1
Janowick, D.2
-
41
-
-
0344840856
-
Design and biological activity of a series of small, low molecular weight farnesyl protein transferase inhibitors
-
Abst 2612
-
Williams, T.M., Ciccarone, T.M., MacTough, S.C. et al. Design and biological activity of a series of small, low molecular weight farnesyl protein transferase inhibitors. Proc Am Assoc Cancer Res 1995, 36: Abst 2612.
-
(1995)
Proc Am Assoc Cancer Res
, vol.36
-
-
Williams, T.M.1
Ciccarone, T.M.2
TacTough, S.C.3
-
42
-
-
0029986149
-
2-Substituted piperazines as constrained amino acids. Application to the synthesis of potent, noncarboxylic acid inhibitors of farnesyl transferase
-
Williams, T.M., Ciccarone, T.M., MacTough, S.C. et al. 2-Substituted piperazines as constrained amino acids. Application to the synthesis of potent, noncarboxylic acid inhibitors of farnesyl transferase. J Med Chem 1996, 39: 1345-8.
-
(1996)
J Med Chem
, vol.39
, pp. 1345-1348
-
-
Williams, T.M.1
Ciccarone, T.M.2
MacTough, S.C.3
-
43
-
-
15444339430
-
Structure-activity relationships of cysteine-lacking pentapeptide derivatives that inhibit ras farnesyl transferase
-
Leonard, D.M., Shuler, K.R., Poulter, C.J. et al. Structure-activity relationships of cysteine-lacking pentapeptide derivatives that inhibit ras farnesyl transferase. J Med Chem 1997, 40: 192-200.
-
(1997)
J Med Chem
, vol.40
, pp. 192-200
-
-
Leonard, D.M.1
Shuler, K.R.2
Poulter, C.J.3
-
44
-
-
0344409222
-
The SAP of tripeptide inhibitors of ras farnesylprotein transferase
-
April 2-6, Anaheim Abst MEDI 032
-
Bolton, G.L., Creswell, M.W., Hodges, J.C., Gowan, R.C., Scholten, J., Sebolt-Leopold, J.S. The SAP of tripeptide inhibitors of ras farnesylprotein transferase. 209th ACS Natl Meet (April 2-6, Anaheim) 1995, Abst MEDI 032.
-
(1995)
209th ACS Natl Meet
-
-
Bolton, G.L.1
Creswell, M.W.2
Hodges, J.C.3
Gowan, R.C.4
Scholten, J.5
Sebolt-Leopold, J.S.6
-
45
-
-
0344409222
-
Modified peptide inhibitors of ras farnesylprotein transferase
-
April 2-6, Anaheim Abst MEDI 033
-
Bolton, G.L., Creswell, M.W., Hodges, J.C., Gowan, B.C., Scholten, J., Sebolt-Leopold, U.S. Modified peptide inhibitors of ras farnesylprotein transferase. 209th ACS Natl Meet (April 2-6, Anaheim) 1995, Abst MEDI 033.
-
(1995)
209th ACS Natl Meet
-
-
Bolton, G.L.1
Creswell, M.W.2
Hodges, J.C.3
Gowan, B.C.4
Scholten, J.5
Sebolt-Leopold, U.S.6
-
46
-
-
0344840857
-
Modified dipeptide inhibitors of ras farnesyl transferase
-
June 18-22, Ann Arbor
-
Bolton, G.L, Creswell, M.W., Hodges, U.C., Gowan, B.C., Scholten, J., Sebolt-Leopold, J.S. Modified dipeptide inhibitors of ras farnesyl transferase. 25th Natl Med Chem Symp (June 18-22, Ann Arbor) 1996.
-
(1996)
25th Natl Med Chem Symp
-
-
Bolton, G.L.1
Creswell, M.W.2
Hodges, U.C.3
Gowan, B.C.4
Scholten, J.5
Sebolt-Leopold, J.S.6
-
47
-
-
33646758912
-
C-Terminal modifications of histidyl-N-benzylglycinamides to give improved inhibition of ras FTase, cellular activity, and anticancer activity in mice
-
McNamara, D.J., Dobrusin, E., Leonard, D.M. et al. C-Terminal modifications of histidyl-N-benzylglycinamides to give improved inhibition of ras FTase, cellular activity, and anticancer activity in mice. J Med Chem 1997, 40: 3319-22.
-
(1997)
J Med Chem
, vol.40
, pp. 3319-3322
-
-
McNamara, D.J.1
Dobrusin, E.2
Leonard, D.M.3
-
48
-
-
0345272219
-
Cellular activity of histidinyl-(N-benzylglycinamides) against ras farnesyl transferase
-
Abst 2343
-
Sebolt-Leopold, J.S., Gowan, R.C., Latash, M.P. et al. Cellular activity of histidinyl-(N-benzylglycinamides) against ras farnesyl transferase. Proc Am Assoc Cancer Res 1997, 38: Abst 2343.
-
(1997)
Proc Am Assoc Cancer Res
, vol.38
-
-
Sebolt-Leopold, J.S.1
Gowan, R.C.2
Latash, M.P.3
-
49
-
-
0344409221
-
In vivo evaluation of histidine-(N-benzylglycinamides) as inhibitors of ras farnesyl transferase
-
Abst 2344
-
Przybranowski, S.A., Sebolt-Leopold, J.S., Leonard, D. et al. In vivo evaluation of histidine-(N-benzylglycinamides) as inhibitors of ras farnesyl transferase. Proc Am Assoc Cancer Res 1997, 38: Abst 2344.
-
(1997)
Proc Am Assoc Cancer Res
, vol.38
-
-
Przybranowski, S.A.1
Sebolt-Leopold, J.S.2
Leonard, D.3
-
50
-
-
0029586503
-
Novel tricyclic inhibitor of farnesyl protein transferase: Biochemical characterization and inhibition of ras modification in transfected Cos cells
-
Bishop, W.R., Bond, R., Petrin, J. et al. Novel tricyclic inhibitor of farnesyl protein transferase: Biochemical characterization and inhibition of ras modification in transfected Cos cells. J Biol Chem 1995, 270: 30611-8.
-
(1995)
J Biol Chem
, vol.270
, pp. 30611-30618
-
-
Bishop, W.R.1
Bond, R.2
Petrin, J.3
-
51
-
-
0031030828
-
Antitumor 8-chlorobenzocyclohepatapyridines: A new class of selective, non-peptidic, non-sulfhydryl inhibitors of ras farnesylation
-
Mallams, A.K., Njoroge, F.G., Doll, R.J. et al. Antitumor 8-chlorobenzocyclohepatapyridines: A new class of selective, non-peptidic, non-sulfhydryl inhibitors of ras farnesylation. Bioorg Med Chem 1997, 5: 93-9.
-
(1997)
Bioorg Med Chem
, vol.5
, pp. 93-99
-
-
Mallams, A.K.1
Njoroge, F.G.2
Doll, R.J.3
-
52
-
-
18544398961
-
Discovery of novel nonpeptide tricyclic inhibitors of ras farnesyl protein transferase
-
Njoroge, F.G., Doll, R.J., Vibulbhan, V. Discovery of novel nonpeptide tricyclic inhibitors of ras farnesyl protein transferase. Bioorg Med Chem 1997, 5: 101-13.
-
(1997)
Bioorg Med Chem
, vol.5
, pp. 101-113
-
-
Njoroge, F.G.1
Doll, R.J.2
Vibulbhan, V.3
-
53
-
-
15644380004
-
Inhibitors of farnesyl protein transferase. 4-Amido, 4-carbamoyl, and 4-carboxamido derivatives of 1-(8-chloro-6,11-dihydro-5H-benzo[5,6]-cyclohepta[1,2-b]pyridin-11-yl)piperazine and 1-(3-bromo-8-chloro-6,11-dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-yl) piperazine
-
Mallam, A.K., Rossman, R.R., Doll, R.J. et al. Inhibitors of farnesyl protein transferase. 4-Amido, 4-carbamoyl, and 4-carboxamido derivatives of 1-(8-chloro-6,11-dihydro-5H-benzo[5,6]-cyclohepta[1,2-b]pyridin-11-yl)piperazine and 1-(3-bromo-8-chloro-6,11-dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-yl) piperazine. J Med Chem 1998, 41: 877-93.
-
(1998)
J Med Chem
, vol.41
, pp. 877-893
-
-
Mallam, A.K.1
Rossman, R.R.2
Doll, R.J.3
-
54
-
-
7844233665
-
(+)-4-2-[4-(8-Chloro-3, 10-dibromo-6, 11-dihydro-5H-benzo[5,6]cyclohepta[1,2-b]-pyridin-11(R)-yl)-1 -piperidinyl-2-oxo-ethyl]-1 -piperidinecarboxamide (SCH-66336): A very potent farnesyl protein transferase inhibitor as a novel antitumor agent
-
Njoroge, F.G., Taveras, A.G., Kelly, J. et al. (+)-4-[2-[4-(8-Chloro-3, 10-dibromo-6, 11-dihydro-5H-benzo[5,6]cyclohepta[1,2-b]-pyridin-11(R)-yl)-1 -piperidinyl)-2-oxo-ethyl]-1 -piperidinecarboxamide (SCH-66336): A very potent farnesyl protein transferase inhibitor as a novel antitumor agent. J Med Chem 1998, 48:4890-902.
-
(1998)
J Med Chem
, vol.48
, pp. 4890-4902
-
-
Njoroge, F.G.1
Taveras, A.G.2
Kelly, J.3
-
55
-
-
15444345862
-
Potent, selective, and orally bioavailable tricyclic pyridyl acetamide N-oxide inhibitors of farnesyl protein transferase with enhanced in vivo antitumor activity
-
Njoroge, F.G., Vibulbhan, B., Pinto, P. et al. Potent, selective, and orally bioavailable tricyclic pyridyl acetamide N-oxide inhibitors of farnesyl protein transferase with enhanced in vivo antitumor activity. J Med Chem 1998, 41: 1561-7.
-
(1998)
J Med Chem
, vol.41
, pp. 1561-1567
-
-
Njoroge, F.G.1
Vibulbhan, B.2
Pinto, P.3
-
56
-
-
0344840854
-
-
Janssen Pharmaceuticals NV. WO9716443
-
Janssen Pharmaceuticals NV. WO9716443.
-
-
-
-
57
-
-
0344840855
-
-
Janssen Pharmaceuticals NV. WO9721701
-
Janssen Pharmaceuticals NV. WO9721701.
-
-
-
-
58
-
-
0000179878
-
R115777, a novel farnesyl protein transferase inhibitor (FTI): Biochemical and cellular effects in H-ras and K-ras dominant systems
-
Abst 1848
-
End, D., Skrzat, S., Devine, A. et al. R115777, a novel farnesyl protein transferase inhibitor (FTI): Biochemical and cellular effects in H-ras and K-ras dominant systems. Proc Am Assoc Cancer Res 1998, 39: Abst 1848.
-
(1998)
Proc Am Assoc Cancer Res
, vol.39
-
-
End, D.1
Skrzat, S.2
Devine, A.3
-
59
-
-
0000179877
-
R115777, a novel imidazole farnesyl protein transferase inhibitor (FTI) with potent oral antitumor activity
-
Abst 2169
-
Skrzat, S., Angibaud, P., Venet, M., Sanz, G., Bowden, C., End, D. R115777, a novel imidazole farnesyl protein transferase inhibitor (FTI) with potent oral antitumor activity. Proc Am Assoc Cancer Res 1998, 39: Abst 2169.
-
(1998)
Proc Am Assoc Cancer Res
, vol.39
-
-
Skrzat, S.1
Angibaud, P.2
Venet, M.3
Sanz, G.4
Bowden, C.5
End, D.6
|